Preliminary sales figures of JSC Olainfarm for May 2011 show that sales have increased by 52% compared to the same period one year ago and have reached 2.9 million lats (4.13 million euro). The most rapid increase in sales was experienced in Moldova (by 171%), Ukraine (by 168%), Latvia (by 85%) and Georgia where the sales have grown by 58%. The major sales markets of JSC Olainfarm during May of 2011 were Russia, Ukraine, Latvia, Kazakhstan and Belarus.
|May, 2011||% of total sales||% change to May 2010|
During five months of 2001 preliminary sales of JSC Olainfarm were 14.22 million lats (20.23 million euro), which represents an increase by 41% compared to similar period of 2010. The fastest growth was seen in Canada, where sales grew by more than 30 times, Moldova by 144%, Uzbekistan (by 118%), Ukraine (by 112%) UK (by 100%) and Latvia, where sales grew by 66%. The major sales markets of JSC Olainfarm during first five months of 2011 were Russia, Ukraine, Belarus, Latvia and the UK.
|5 months of 2011||% of total sales||% change to 5 months of 2010|
Operating plan and budget of JSC Olainfarm for 2011 provides that company plans the sales of 29.4 million lats (41.8 million Euro) and the net profit of 5.1 million lats (7.3 million Euro).
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717
Cell: +371 2 6448 873